20 May 2013
Keywords: guilford, sees, progress, across, programs, product, phase
Article | 04 November 1999
With one product in Phase III clinical trials and several others inPhase I or II development, Guilford Pharmaceuticals might be ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
4 November 1999
17 May 2013
© 2013 thepharmaletter.com